The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2016

Filed:

Oct. 23, 2013
Applicant:

Yuhan Corporation, Seoul, KR;

Inventors:

Chan-Sun Park, Gyeonggi-do, KR;

Young-Hwan Kim, Gyeonggi-do, KR;

Gyu-Jin Lee, Gyeonggi-do, KR;

Youn Hur, Gyeonggi-do, KR;

Eun-Hye Jung, Gyeonggi-do, KR;

Hee-Jae Tak, Gyeonggi-do, KR;

Seung-Yub Shin, Seoul, KR;

Ho-Jin Lee, Seoul, KR;

Chun-Ho Lee, Seoul, KR;

Koo-Yeon Lee, Gangwon-do, KR;

Assignee:

YUHAN CORPORATION, Seoul, KR;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 403/04 (2006.01); C07D 231/06 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 401/06 (2006.01);
U.S. Cl.
CPC ...
C07D 403/10 (2013.01); C07D 231/06 (2013.01); C07D 401/06 (2013.01); C07D 401/10 (2013.01); C07D 403/04 (2013.01);
Abstract

The present invention provides a 4,5-dihydro-1H-pyrazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The 4,5-dihydro-1H-pyrazole derivative or its pharmaceutically acceptable salt effectively increases the LXR transcriptional activity, and therefore can be usefully applied for preventing or treating a dysfunction in cholesterol metabolism, such as cholesterol gallstone, hyperlipidemia, or coronary atherosclerosis.


Find Patent Forward Citations

Loading…